More than 90% of dermatology clinicians surveyed by Leo Pharma say their patients with moderate to severe chronic hand eczema ...

Danish dermatology specialist LEO Pharma could be just weeks away from EU approval for delgocitinib, a treatment for chronic hand eczema (CHE) considered to be its top pipeline prospect.

Dermatology specialist LEO Pharma has built the case for its first ... for the condition in a phase 3 trial. LEO’s topical cream formulation of the pan-JAK inhibitor proved to be more effective ...